"We conduct clinical research studies for those suffering from Alzheimer's Disease, Parkinson's Disease, MS, Migraine Heachaches."

During the past decade, Infinity Clinical Research conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 10 clinical trials were completed, i.e. on average, 83.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 5 clinical trials were completed. i.e. 166.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Infinity Clinical Research" #1 sponsor was "Allergan" with 3 trials, followed by "Eisai Inc." with 3 trials sponsored, "Eli Lilly and Company" with 3 trials sponsored, "Revance Therapeutics, Inc." with 3 trials sponsored and "Boehringer Ingelheim" with 3 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Infinity Clinical Research" #1 collaborator was "Syneos Health" with 2 trials as a collaborator, "Alzheimer's Association" with 1 trials as a collaborator, "Biogen" with 1 trials as a collaborator, "Clinilabs, Inc." with 1 trials as a collaborator and "National Institute on Aging (NIA)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Infinity Clinical Research" are "Alzheimer's Disease" (5 trials), "Parkinson's Disease" (3 trials), "Alzheimer Disease" (2 trials), "Cervical Dystonia" (2 trials) and "Migraine" (2 trials). Many other conditions were trialed in "Infinity Clinical Research" in a lesser frequency.

Most popular intervention types in "Infinity Clinical Research" are "Drug" (20 trials), "Biological" (4 trials), "Other" (4 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Atogepant" (2 trials), "Galcanezumab" (2 trials), "15mg T3D-959" (1 trials) and "2 mg perampanel" (1 trials). Other intervention names were less common.

The vast majority of trials in "Infinity Clinical Research" are 27 trials for "All" genders.

Currently, there are NaN active trials in "Infinity Clinical Research". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 22 completed trials in Infinity Clinical Research, 1 suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Infinity Clinical Research, 0 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".